Trials / Not Yet Recruiting
Not Yet RecruitingNCT07169149
Study About Drug Resistance of Mycobacterium Tuberculosis
Study of the Prevalence and Patterns of Drug Resistance of Mycobacterium Tuberculosis Using GeneXpert (MTB/RIF) and Xpert (MTB/XDR) Assays
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- Sohag University · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- —
Summary
Tuberculosis is a major cause of ill health and one of the leading causes of death worldwide. Early, rapid and accurate diagnosis of all TB patients and prompt treatment with any form of drug-susceptible or drug resistant TB is fundamental. Identifying the pattern of drug resistance will ensure that the most effective therapy can be selected. The aim of this study is to assess the prevalence and patterns of drug resistance of mycobacterium tuberculosis and to detect the possible risk factors associated with resistant cases.
Conditions
Timeline
- Start date
- 2025-10-01
- Primary completion
- 2026-08-01
- Completion
- 2027-02-01
- First posted
- 2025-09-11
- Last updated
- 2025-09-11
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07169149. Inclusion in this directory is not an endorsement.